Clinical Trial: An Open-label Long-term Safety Study of Buntanetap in Participants With AD

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757204) titled 'An Open-label Long-term Safety Study of Buntanetap in Participants With AD' on July 31.

Brief Summary: This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.

Study Start Date: Sept. 21

Study Type: INTERVENTIONAL

Condition: Alzheimer's Dementia (AD)

Intervention: DRUG: buntanetap/posiphen

buntanetap 30 mg daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Annovis Bio Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....